Deworming drug, levamisole, is being evaluated by the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) following concerns about its links with leukoencephalopathy.
Health Secretary Wes Streeting has launched an independent review into the prevalence, trends, and clinical management of mental health conditions, attention deficit hyperactivity disorder (ADHD), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results